Cystic adenomyosis is a rare form of adenomyosis of the uterine myometrium that has been described in older adults. This condition has not previously been reported in the pediatric radiology literature. In this case report, we describe an adenomyotic cyst in an adolescent girl that was imaged with US, CT, and MR and proved by surgical pathology. Understanding of the radiologic features of cystic adenomyosis is important for noninvasive diagnosis and effective medical/surgical management.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00247-008-0948-0DOI Listing

Publication Analysis

Top Keywords

adenomyotic cyst
8
cystic adenomyosis
8
cyst uterus
4
uterus adolescent
4
adolescent cystic
4
adenomyosis rare
4
rare form
4
form adenomyosis
4
adenomyosis uterine
4
uterine myometrium
4

Similar Publications

Clear Cell Carcinoma Arising From Adenomyotic Cyst: A Case Report.

Cureus

October 2024

Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.

Article Synopsis
  • - A 38-year-old woman with a uterine tumor was diagnosed with clear cell carcinoma arising from an adenomyotic cyst, after imaging and elevated tumor markers indicated potential malignancy.
  • - Initial surgery aimed at preserving her fertility involved a myomectomy, but further examinations confirmed clear cell carcinoma and a subsequent hysterectomy and other procedures revealed metastasis to lymph nodes.
  • - The patient was treated with chemotherapy and immunotherapy, but 18 months later showed signs of treatment resistance with new liver and lymph node metastases.
View Article and Find Full Text PDF

Introduction: Fallopian tube cancer is a rare tumor, representing between 0.3 and 1.8 % of all malignant tumors in the gynecological sphere.

View Article and Find Full Text PDF

Objective: This study elucidated the efficacy of Relugolix (REL) on the reduction of uterine volume and clinical symptoms for the treatment of adenomyosis.

Methods: We conducted a retrospective cohort study of patients who received REL (40 mg for about 20 weeks) and who underwent a hysterectomy for adenomyosis or fibroids. We divided patients into two groups: adenomyosis coexisting with fibroids (Group A) and fibroids only (Group B); the groups were determined by a postoperative pathological examination.

View Article and Find Full Text PDF

Objective: To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation.

Data Sources: We searched electronic databases such as Web of Science, MEDLINE, Cochrane Library, EMBASE, ClinicalTrials.gov , and Google Scholar from January 2000 to January 2022.

View Article and Find Full Text PDF

Endometrial Cancer Arising in Adenomyosis (EC-AIA): A Systematic Review.

Cancers (Basel)

February 2023

Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.

Article Synopsis
  • Endometrial cancer arising in adenomyosis (EC-AIA) is a rare and challenging uterine disease with malignant transformations often occurring in menopausal women.
  • The study reviewed existing literature from 2002 to 2022, analyzing 37 cases found in case reports and series, highlighting that EC-AIA shares symptoms with regular endometrial cancer but is more difficult to diagnose preoperatively.
  • Key findings indicate EC-AIA has a higher prevalence of non-endometrioid histotypes and advanced cancer stages, leading to a worse prognosis, emphasizing the need for more extensive future research to better understand this condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!